154 related articles for article (PubMed ID: 30509492)
21. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
[TBL] [Abstract][Full Text] [Related]
22. Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols.
Stevens R; Rüsch D; Solt K; Raines DE; Davies PA
J Pharmacol Exp Ther; 2005 Jul; 314(1):338-45. PubMed ID: 15831437
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the 5-HT3A receptor-mediated current by alkyl 4-hydroxybenzoates isolated from the seeds of Nelumbo nucifera.
Youn UJ; Lee JH; Lee YJ; Nam JW; Bae H; Seo EK
Chem Biodivers; 2010 Sep; 7(9):2296-302. PubMed ID: 20860031
[TBL] [Abstract][Full Text] [Related]
24. Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.
Lochner M; Lummis SC
Biophys J; 2010 Apr; 98(8):1494-502. PubMed ID: 20409468
[TBL] [Abstract][Full Text] [Related]
25. Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT
Powell AD; Grafton G; Roberts A; Larkin S; O'Neill N; Palandri J; Otvos R; Cooper AJ; Ulens C; Barnes NM
Br J Pharmacol; 2016 Dec; 173(24):3467-3479. PubMed ID: 27677804
[TBL] [Abstract][Full Text] [Related]
26. Investigation of 5-HT
Kojima SI; Kojima K; Fujita T
Eur J Pharmacol; 2017 Mar; 799():196-200. PubMed ID: 28189582
[TBL] [Abstract][Full Text] [Related]
27. Serotonergic agents act on 5-HT
Faingold CL; Randall M; Zeng C; Peng S; Long X; Feng HJ
Epilepsy Behav; 2016 Nov; 64(Pt A):166-170. PubMed ID: 27743549
[TBL] [Abstract][Full Text] [Related]
28. Conformational Changes in the 5-HT
Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
[TBL] [Abstract][Full Text] [Related]
29. The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease.
Zhang QJ; Li LB; Niu XL; Liu J; Gui ZH; Feng JJ; Ali U; Hui YP; Wu ZH
Brain Res; 2011 Apr; 1384():69-79. PubMed ID: 21291871
[TBL] [Abstract][Full Text] [Related]
30. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
Riga MS; Sánchez C; Celada P; Artigas F
Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
[TBL] [Abstract][Full Text] [Related]
31. 5-HT(3) receptor expression in the mouse vestibular ganglion.
Takimoto Y; Ishida Y; Nakamura Y; Kamakura T; Yamada T; Kondo M; Kitahara T; Uno A; Imai T; Horii A; Okazaki S; Nishiike S; Inohara H; Shimada S
Brain Res; 2014 Apr; 1557():74-82. PubMed ID: 24530269
[TBL] [Abstract][Full Text] [Related]
32. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
33. RS-056812-198: partial agonist on native and antagonist on cloned 5-HT3 receptors.
Van Hooft JA; Vijverberg HP
Eur J Pharmacol; 1997 Mar; 322(2-3):229-33. PubMed ID: 9098692
[TBL] [Abstract][Full Text] [Related]
34. SR 57227A, a serotonin type-3 receptor agonist, as a candidate analgesic agent targeting nociplastic pain.
Nakamura Y; Sumi T; Mitani O; Okamoto T; Kubo E; Masui K; Kondo M; Koyama Y; Usui N; Shimada S
Biochem Biophys Res Commun; 2022 Sep; 622():143-148. PubMed ID: 35863088
[TBL] [Abstract][Full Text] [Related]
35. Serotonin3 receptor agonists attenuate glutamate-induced firing in rat hippocampal CA1 pyramidal cells.
Zhang JY; Zeise ML; Wang RY
Neuropharmacology; 1994; 33(3-4):483-91. PubMed ID: 7984287
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of a rat 5-hydroxytryptamine type3 receptor subunit (r5-HT3A(b)) expressed in Xenopus laevis oocytes.
Mair ID; Lambert JJ; Yang J; Dempster J; Peters JA
Br J Pharmacol; 1998 Aug; 124(8):1667-74. PubMed ID: 9756382
[TBL] [Abstract][Full Text] [Related]
37. Ionotropic 5-HT3 receptor agonist-induced motor responses in the hindlimbs of paraplegic mice.
Guertin PA; Steuer I
J Neurophysiol; 2005 Nov; 94(5):3397-405. PubMed ID: 16049141
[TBL] [Abstract][Full Text] [Related]
38. Activation and modulation of recombinantly expressed serotonin receptor type 3A by terpenes and pungent substances.
Ziemba PM; Schreiner BS; Flegel C; Herbrechter R; Stark TD; Hofmann T; Hatt H; Werner M; Gisselmann G
Biochem Biophys Res Commun; 2015 Nov; 467(4):1090-6. PubMed ID: 26456648
[TBL] [Abstract][Full Text] [Related]
39. 5-Fluorotryptamine is a partial agonist at 5-HT3 receptors, and reveals that size and electronegativity at the 5 position of tryptamine are critical for efficient receptor function.
Bower KS; Price KL; Sturdee LE; Dayrell M; Dougherty DA; Lummis SC
Eur J Pharmacol; 2008 Feb; 580(3):291-7. PubMed ID: 18082160
[TBL] [Abstract][Full Text] [Related]
40. Menthol inhibits 5-HT3 receptor-mediated currents.
Ashoor A; Nordman JC; Veltri D; Yang KH; Shuba Y; Al Kury L; Sadek B; Howarth FC; Shehu A; Kabbani N; Oz M
J Pharmacol Exp Ther; 2013 Nov; 347(2):398-409. PubMed ID: 23965380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
